TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.

Shareholders will vote on six ordinary resolutions:

1. 2025 board of directors’ work report 2. 2025 performance report of independent non-executive directors 3. 2025 annual financial report 4. 2025 profit distribution plan 5. Remuneration plan for the current board session’s directors 6. Appointment of the external auditor for the 2026 fiscal year

H-shareholders wishing to appoint a proxy must submit the completed form—with any required notarised authorisations—to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, no later than 2:00 p.m. on 28 June 2026. Joint shareholders may vote through the first-named holder on the register, and any alterations to the proxy form must be initialled by the signatory.

The company emphasised that proxies may vote at their discretion on any resolution lacking specific shareholder instructions and on any other properly introduced business at the meeting.